The role of a type of liver cell in liver cancer is reviewed

by Fundació Clínic per a la Recerca Biomèdica

IDIBAPS researchers have reviewed the role of fibroblasts, a type of cell found in the liver, in the progression of liver cancer, both hepatocellular carcinoma and cholangiocarcinoma.

Read more

New advances in the analysis of mechanisms during the development of hepatocellular carcinoma

by CIC bioGUNE

Researchers from IDIBELL, CIC bioGUNE and CIBEREHD discover that a protein called NOX4, which was previously thought to cause cell death, can also help tumor growth. The study published in the journal...

Read more

The role of immunotherapy in hepatocellular carcinoma

by Fundació Clínic per a la Recerca Biomèdica

Immunotherapy has revolutionized the treatment of hepatocellular carcinoma. Researchers from the Hospital Clínic-IDIBAPS have published a review in the journal Nature Reviews – Clinical Oncology in...

Read more

AECC is funding a project led by Nabil Djouder to find treatments for the most common type of liver cancer

by CNIO - Centro Nacional de Investigaciones Oncológicas

Nabil Djouder, lead researcher of the Growth Factors, Nutrients and Cancer Group at the Spanish National Cancer Research Centre (CNIO), is receiving funding from the Spanish Association Against Cancer...

Read more

A meta-analysis of phase-III trials shows that immunotherapy is more efficacious in liver cancer of viral origin than of nonviral origin

by Fundació Clínic per a la Recerca Biomèdica

Researchers at IDIBAPS have led a study, published in the journal Gastroenterology, in which they analyzed the clinical trials published in the past 20 years on hepatocellular carcinoma (2000-2020) an...

Read more

Molecular map of hepatocellular carcinoma caused by fatty liver disease revealed

by Fundació Clínic per a la Recerca Biomèdica

IDIBAPS researchers have drafted a molecular map of the most common type of liver cancer, hepatocellular carcinoma, when the origin is fatty liver disease or nonalcoholic steatohepatitis.

Read more

CIC bioGUNE researchers describe a new microRNA determinant of response to sorafenib in patients with hepatocellular carcinoma

by CIC bioGUNE

Researchers from the Liver Disease Laboratory at CIC bioGUNE, a member of the Basque Research & Technology Alliance (BRTA), have described a new microRNA, a gene expression regulator molecule, which d...

Read more

A new study about the reprogramming of lipid metabolism to combat cellular hepatocarcinoma

by Hospital Universitari de Bellvitge

A work coordinated by Isabel Fabregat – group leader of TGF-β and Cancer group at IDIBELL and CIBEREHD – University of Barcelona – studies the reprogramming of lipid metabolism and provides new...

Read more

A study in Nature concludes that immunotherapy is less efficacious in nonviral liver cancer

by Fundació Clínic per a la Recerca Biomèdica

An article published in the journal Nature suggests that immunotherapy is effective in patients with HCC of viral origin but does not increase survival of patients with HCC caused by alcohol abuse or ...

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

New advances in cancer viral immunothera...

by Universitat de Barcelona

It has been developed a new strain of vaccinia virus, which can replic...

Photos Stream